Event Details

Join us at the  5th Annual Allogeneic Cell Therapies Summit to discuss the specific challenges in the development of allogeneic CAR-T, TCR, NK, Gamma-Delta, and iPSC therapies.

Wednesday, May 24, 4:30 PM (EST)

• Session: Ushering in the Next Wave of Universal Cell Therapy – Future Directions
• Presentation: Developing Next-Generation Allogeneic Therapies for Solid Tumors Based on γδ T cells
  Discussing characteristics of gamma delta T cells as source for an allogeneic cell therapy approach
  Redirecting gamma delta T cells with TCRs against peptide-HLA targets to combat solid tumors
  Exploring next-gen strategies to potentiate anti-tumor activity
• Presenter: Ali Mohamed, Senior VP CMC, Immatics

We are looking forward to meeting you!

For more information visit the event's homepage.